000 | 01944 a2200481 4500 | ||
---|---|---|---|
005 | 20250516144156.0 | ||
264 | 0 | _c20131104 | |
008 | 201311s 0 0 eng d | ||
022 | _a1950-6007 | ||
024 | 7 |
_a10.1016/j.biopha.2013.01.004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aShin, Dong Yeok | |
245 | 0 | 0 |
_aDecitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells. _h[electronic resource] |
260 |
_bBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _cMay 2013 |
||
300 |
_a305-11 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xpharmacology |
650 | 0 | 4 |
_aAzacitidine _xanalogs & derivatives |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCyclin-Dependent Kinase Inhibitor p21 _xgenetics |
650 | 0 | 4 | _aDecitabine |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 |
_aG2 Phase Cell Cycle Checkpoints _xdrug effects |
650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
650 | 0 | 4 | _aGene Knockdown Techniques |
650 | 0 | 4 | _aHCT116 Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aM Phase Cell Cycle Checkpoints _xdrug effects |
650 | 0 | 4 |
_aRNA, Small Interfering _xadministration & dosage |
650 | 0 | 4 |
_aStomach Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
700 | 1 | _aSung Kang, Ho | |
700 | 1 | _aKim, Gi-Young | |
700 | 1 | _aKim, Wun-Jae | |
700 | 1 | _aYoo, Young Hyun | |
700 | 1 | _aChoi, Yung Hyun | |
773 | 0 |
_tBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _gvol. 67 _gno. 4 _gp. 305-11 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biopha.2013.01.004 _zAvailable from publisher's website |
999 |
_c22666214 _d22666214 |